Innovative breakthroughs, shaping new advantages; integration and optimization, striving for a hundred years
Release time:
2020-08-14
Innovation Breakthrough and Shaping New Advantages; Integration and Optimization, Endeavour Centennial Road
-Chairman's Message
Spring Festival is coming, we are about to enter the Year of the Dog in 1898, and our Jianfeng Group will also enter the 60th year since its inception. The past sixty years, is our peak forge ahead in sixty years, the continuous development and growth of sixty years. Especially since the reform and opening up, we have boldly explored, through measures such as alliances with township enterprises, stock issuance, cross-industry development, cooperation with central enterprises, transformation and upgrading, etc., we have blazed a path that everyone has never walked, and we have also written our peak 60 years. The glory of the year. This is not only a history of struggle, but also a history of innovation, but also a glorious history of the continuous progress of peak people.
Innovation Master Xiong Peter (Joseph Alois Schumpeter ) once said: Any technological transformation, process reengineering, management improvement, and process optimization belong to the category of innovation. With the development of science and technology, AI has become a reality from an assumption; the rise of emerging industries such as information technology and e-commerce has changed people's traditional thinking mode and way of life. New changes are taking place in the world every day, and the source of this change is "innovation". The world is not what it used to be, and the peak is not what it used to be. It is precisely because of our persistence in continuous innovation that we have flourished in the past 60 years. Innovation requires passion, courage and wisdom. In the future, we still need to continue to innovate in order to make the peak stand firm, continue to be strong, and move towards higher and farther goals.
Comrades, the convening of the 19th National Congress of the Communist Party of China marks that Chinese society has entered a new era. The development of enterprises is undergoing kinetic energy conversion, from high-speed growth to high-quality development. In today's era, the only constant is "change", "survival of the fittest" is the eternal truth. After these years of development, our cement has made extraordinary achievements in industrial layout, technological innovation, and technological transformation of facilities; our medicine has made gratifying achievements in plate layout and product research and development, but in the face of the new era, we will still face great challenges in the Red Sea market. Sixty years of a Jiazi, in the year of the opening of a Jiazi under the peak, we will use advanced strategies, bold innovations, and self-revolution to forge our century-old road. On the road of future development, we should use the wisdom of peak people and persist in continuous innovation to create new advantages; we should keep up with the pace of the development of cement in the world, strengthen ourselves through continuous learning, use advanced technological concepts, and take high-quality development as the main line to enhance the sustainable competitive advantage of our cement and add vitality to the traditional industry; our pharmaceutical industry, based on raw materials, chemical pharmaceuticals, and traditional Chinese medicine, combined with the evolution of the modern disease spectrum, it will play a greater role in tumor pharmaceuticals, infant medicines, and elderly medicines, and do a good job in the "smile curve" of products developed and sold at both ends. In the new year, we will increase investment in the construction of API bases and international generic drug bases, further integrate and optimize new drug research and development, production and sales, and accelerate the development of existing clinical and preclinical series of innovative drugs. The speed of research and development, with customer value and customer needs as our work goals, continuously improve the level of preparations, continuously accelerate the speed of research and development, and continuously improve the quality of drugs. The requirements for the full coverage of the consistency evaluation of domestic preparations have been clear. Only by making truly high-quality and effective products can we win the future and the market.
On the journey of "creating a century-old peak", we will inherit and carry forward the peak spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top, and bravely climb the peak"; we must "innovation, performance, integrity, Responsibility, tolerance" values to arm our employees. We should take excellent enterprises with excellent performance, leading technology, first-class management, well-known brand and core competitiveness as our ultimate goal; we should enhance the core competence of enterprises with innovative mechanism, optimize the layout, enhance the market competitiveness, and enhance the organizational competitiveness through integration and optimization. In this way, there is hope for our peak, and there is hope for our future. "Hundred years of peak" is not a dream!
"Xiongguan Mandao is really like iron, and now we are striding forward from the beginning". Today, we stand at a new historical starting point with the peak cause. Let's make positive progress and forge ahead with the peak 100-year road!
Chairman of Jianfeng Group Jiang Xiaomeng
February 7, 2018
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11